Meeting
2024 ASCO Annual Meeting
Pathogenic germline variant discovery in plasma cell disorders: Insights from genetic counseling referrals and testing.
Authors
Saoirse Bodnar
Icahn School of Medicine at Mount Sinai, New York, NY
Saoirse Bodnar , Tehilla Brander , Manisha M Balwani , Sundar Jagannath , Samir Parekh , Santiago Thibaud
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Hereditary Cancer Syndromes
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 10619)
DOI
10.1200/JCO.2024.42.16_suppl.10619
Abstract #
10619
Poster Bd #
146
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Translating potential germline findings from tumour profiling into routine clinical care.
First Author: Milita Zaheed
Poster
2023 ASCO Annual Meeting
Somatic profiling guides germline genetic testing in patients with mutations in cancer predisposition genes.
First Author: Sourat Darabi
Poster
2021 ASCO Annual Meeting
Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types.
First Author: Kristen Hanson
Poster
2018 ASCO Annual Meeting
Feasibility of perioperative multi-gene panel testing (MGPT) in cancer patients eligible for hereditary genetic evaluation (GE): The PROTECT pilot.
First Author: Michael J. Hall